title: [Influenza vaccination coverage in asthmatic children in  France in 2006-2007].
abstract: In France, an annual seasonal influenza vaccination has been recommended since 2000 for patients suffering from chronic respiratory diseases, including asthma. Each year, a free influenza vaccination voucher is sent by the French Public Health Insurance authorities to patients with chronic respiratory disease, including severe asthma. In November 2006, this measure was extended to all asthmatic patients, irrespective of asthma severity. The present paper examines the 2006-2007 influenza vaccination coverage rate in 433 asthmatic children aged six to 17 years (mean age: 9.5 years; male: 61%) who consulted a pediatric pulmonologist between March and September 2007 in eight hospitals throughout France. The influenza vaccination coverage rate was 15.7% for the 2006-2007 season (13.9% for the 2005-2006 season and 10.9% for the 2004-2005 season). General practitioners vaccinated 72.1% of the children. Lack of information (42%) was the most frequently reported reason for non-vaccination. Free vouchers (received by 39.6% of the children) significantly increased the vaccination coverage rate (31% versus 5.9%; p < 0.001). In France, in 2006-2007, the influenza vaccination coverage rate in asthmatic children was far below the national public health objective to achieve for the year 2008 (at least 75%). Concerted action is needed to improve the influenza vaccination coverage rate in asthmatic children.
authors.affiliation: Service de pédiatrie-pneumologie-allergologie hôpital-des-enfants, CHU de Toulouse, 330 avenue de Grande-Bretagne, 31059 Toulouse cedex 9, France.
authors.forename: F
authors.initials: F
authors.lastname: Rancé
authors.forename: C
authors.initials: C
authors.lastname: Chave
authors.forename: J
authors.initials: J
authors.lastname: de Blic
authors.forename: A
authors.initials: A
authors.lastname: Deschildre
authors.forename: L
authors.initials: L
authors.lastname: Donato
authors.forename: J-C
authors.initials: JC
authors.lastname: Dubus
authors.forename: M
authors.initials: M
authors.lastname: Fayon
authors.forename: A
authors.initials: A
authors.lastname: Labbe
authors.forename: M
authors.initials: M
authors.lastname: Le Bourgeois
authors.forename: C
authors.initials: C
authors.lastname: Llerena
authors.forename: G
authors.initials: G
authors.lastname: Le Manach
authors.forename: I
authors.initials: I
authors.lastname: Pin
authors.forename: C
authors.initials: C
authors.lastname: Santos
authors.forename: C
authors.initials: C
authors.lastname: Thumerelle
authors.forename: M
authors.initials: M
authors.lastname: Aubert
authors.forename: C
authors.initials: C
authors.lastname: Weil-Olivier
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000150:complications; D002648:Child; D005260:Female; D005602:France; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000150:complications / Q000517:prevention & control*; D008297:Male; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D007252:Influenza Vaccines